脑星形细胞瘤

Buckner JC, Shaw EG, Pugh SL, et al. Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma. N Engl J Med. 2016;374:1344-1355.

• 全文
• 摘要

National Institute for Health and Care Excellence. Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma. June 2007. http://www.nice.org.uk/ (last accessed 7 October 2016).

• 全文

Ryken TC, Frankel B, Julien T, et al. Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery. J Neurooncol. 2008;89:271-286.

• 摘要

1.  Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803-820.

• 全文
• 摘要

2.  Burkhard C, Di Patre PL, Schuler D, et al. A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma. J Neurosurg. 2003;98:1170-1174.

• 摘要

3.  Arita K, Kurisu K, Tominaga A, et al. Intrasellar pleomorphic xanthoastrocytoma: case report. Neurosurgery. 2002;51:1079-1082.

• 摘要

4.  Epstein F, Farmer JP. Brainstem glioma growth patterns. J Neurosurg. 1993;78:408-412.

• 摘要

5.  Reigel DH, Scarff TB, Woodford JE. Biopsy of pediatric brain stem tumors. Childs Brain. 1979;5:329-340.

• 摘要

6.  McKinney PA. Brain tumours: incidence, survival, and aetiology. J Neurol Neurosurg Psychiatry. 2004;75(suppl 2):ii12-ii17.

• 全文
• 摘要

7.  Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64:479-489.

• 摘要

8.  Larjavaara S, Mantyla R, Salminen T, et al. Incidence of gliomas by anatomic location. Neuro Oncol. 2007;9:319-325.

• 全文
• 摘要

9.  Central Brain Tumor Registry of the United States. Statistical report: primary brain tumors in the United States, 1995-1999. Hinsdale, IL: CBTRUS; 2002.

• 全文

10.  Braffman BH, Bilaniuk LT, Naidich TP, et al. MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review. Radiology. 1992;183:227-238.

• 摘要

11.  Kitange GJ, Templeton KL, Jenkins RB. Recent advances in molecular genetics of primary gliomas. Curr Opin Oncol. 2003;15:197-203.

• 摘要

12.  Guthrie BL, Laws E. Supratentorial low-grade gliomas. Neurosurg Clin North Am. 1990;1:37-48.

• 摘要

13.  Velema JP, Walker AM. The age curve of nervous system tumor incidence in adults: common shape but changing levels by sex, race and geographical location. Int J Epidemiol. 1987;16:177-183.

• 摘要

14.  Prados MD, Gutin PH, Phillips TL, et al. Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys. 1992;23:3-8.

• 摘要

15.  Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4:278-299.

• 全文
• 摘要

16.  Rothman KJ. Health effects of mobile telephones. Epidemiology. 2009;20:653-655.

• 摘要

17.  Hardell L, Carlberg M, Hansson Mild K. Use of mobile phones and cordless phones is associated with increased risk for glioma and acoustic neuroma. Pathophysiology. 2013;20:85-110.

• 全文
• 摘要

18.  Corle C, Makale M, Kesari S. Cell phones and glioma risk: a review of the evidence. J Neurooncol. 2012;106:1-13.

• 摘要

19.  Kan P, Simonsen SE, Lyon JL, et al. Cellular phone use and brain tumor: a meta-analysis. J Neurooncol. 2008;86:71-78.

• 摘要

20.  Myung SK, Ju W, McDonnell DD, et al. Mobile phone use and risk of tumors: a meta-analysis. J Clin Oncol. 2009;27:5565-5572.

• 全文
• 摘要

21.  Ahlbom A, Feychting M, Green A, et al. Epidemiologic evidence on mobile phones and tumor risk: a review. Epidemiology. 2009;20:639-652.

• 摘要

22.  Samkange-Zeeb F, Schlehofer B, Schüz J, et al. Occupation and risk of glioma, meningioma and acoustic neuroma: results from a German case-control study (interphone study group, Germany). Cancer Epidemiol. 2010;34:55-61.

• 摘要

23.  Surawicz TS, McCarthy BJ, Kupelian V, et al. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol. 1999;1:14-25.

• 全文
• 摘要

24.  Blatt J, Jaffe R, Deutsch M, et al. Neurofibromatosis and childhood tumors. Cancer. 1986;57:1225-1229.

• 摘要

25.  Singhal S, Birch JM, Kerr B, et al. Neurofibromatosis type I and sporadic optic gliomas. Arch Dis Child. 2002;87:65-70.

• 摘要

26.  Tao ML, Barnes PD, Billett AL, et al. Childhood optic chiasm gliomas: radiographic response following radiotherapy and long-term clinical outcome. Int J Radiat Oncol Biol Phys. 1997;39:579-587.

• 摘要

27.  Listernick R, Charrow J, Greenwald MJ, et al. Natural history of optic nerve pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr. 1994;125:63-66.

• 摘要

28.  Shepherd CW, Scheithauer BW, Gomez MR, et al. Subependymal giant cell astrocytoma: a clinical, pathological, and cytometric study. Neurosurgery. 1991;28:864-868.

• 摘要

29.  Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990;250:1233-1238.

• 摘要

30.  Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot's syndrome. N Engl J Med. 1995;332:839-847.

• 全文
• 摘要

31.  Paulino AC, Mai WY, Chintagumpala M, et al. Radiation-induced malignant gliomas: is there a role for reirradiation? Int J Radiat Oncol Biol Phys. 2008;71:1381-1387.

• 摘要

32.  Gurney JG, Kadan-Lottick N. Brain and other central nervous system tumors: rates, trends and epidemiology. Curr Opin Oncol. 2001;13:160-166.

• 摘要

33.  Vecht CJ, Wagner GL, Wilms EB. Treating seizures in patients with brain tumors: drug interactions between antiepileptic and chemotherapeutic agents. Semin Oncol. 2003;30:49-52.

• 摘要

34.  Snyder H, Robinson K, Shah D, et al. Signs and symptoms of patients with brain tumors presenting to the emergency department. J Emerg Med. 1993;11:253-258.

• 摘要

35.  DeAngelis LM. Brain tumors. N Engl J Med. 2001;344:114-123.

• 摘要

36.  Whittle IR, Pringle AM, Taylor R. Effects of resective surgery for left-sided intracranial tumors on language function: a prospective study. Lancet. 1998;351:1014-1018.

• 摘要

37.  Wu JS, Zhou LF, Tang WJ, et al. Clinical evaluation and follow-up outcome of diffusion tensor imaging-based functional neuronavigation: a prospective, controlled study in patients with gliomas involving pyramidal tracts. Neurosurgery. 2007;61:935-948.

• 摘要

38.  Grimstad IA, Hirschberg H, Rootwelt K. 99m Tc-hexamethyl propyleneamine oxime leukocyte scintigraphy and C-reactive protein levels in the differential diagnosis of brain abscess. J Neurosurg. 1992;77:732-736.

• 摘要

39.  Lee YY, Van Tassel P, Bruner JM, et al. Juvenile pilocytic astrocytomas: CT and MR characteristics. AJR Am J Roentgenol. 1989;152:1263-1270.

• 全文
• 摘要

40.  Stupp R, Brada M, van den Bent MJ, et al. High-grade glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(suppl 3):iii93-iii101.

• 全文
• 摘要

41.  Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsivant prophylaxis in patients with newly diagnosed brain tumors. Report of the quality standard subcommittee of the American Academy of Neurology. Neurology. 2000;54:1886-1893.

• 摘要

42.  Ater JL, Zhou T, Holmes E, et al. Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group. J Clin Oncol. 2012;30:2641-2647.

• 全文
• 摘要

43.  Packer RJ, Lange B, Ater J, et al. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol. 1993;11:850-856.

• 摘要

44.  Prados MD, Edwards MS, Rabbitt J, et al. Treatment of pediatric low-grade gliomas with nitrosurea-based multiagent chemotherapy regimen. J Neurooncol. 1997;32:235-241.

• 摘要

45.  Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62:753-764.

• 摘要

46.  Tihan T, Fisher PG, Kepner JL, et al. Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neuropathol Exp Neurol. 1999;58:1061-1068.

• 摘要

47.  Buckner JC, Shaw EG, Pugh SL, et al. Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma. N Engl J Med. 2016;374:1344-1355.

• 全文
• 摘要

48.  Stummer W, van den Bent MJ, Westphal M. Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion. Acta Neurochir (Wien). 2011;153:1211-1218.

• 摘要

49.  National Institute for Health and Care Excellence. Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma. June 2007. http://www.nice.org.uk/ (last accessed 7 October 2016).

• 全文

50.  Westphal M, Ram Z, Riddle V, et al. Gliadel wafer in initial surgery for malignant gliomas: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien). 2006;148:269-275.

• 摘要

51.  Hart MG, Grant R, Garside R, et al. Chemotherapy wafers for high grade glioma. Cochrane Database Syst Rev. 2011;(3):CD007294.

• 全文
• 摘要

52.  Wick W, Platten M, Meisner C, et al.Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol. 2012;13:707-715.

• 摘要

53.  Malmström A, Grønberg BH, Marosi C, et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol. 2012;13:916-926.

• 摘要

54.  Buie LW, Valgus J. Bevacizumab: a treatment option for recurrent glioblastoma multiforme. Ann Pharmacother. 2008;42:1486-1490.

• 摘要

55.  Galicich JH, French LA. Use of dexamethasone in the treatment of cerebral edema from brain tumors and brain surgery. AM Pract Dig Treat. 1961;12:169-174.

• 摘要

56.  Fisher BJ, Leighton CC, Vujovic O, et al. Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas. Int J Radiat Oncol Biol Phys. 2001;51:704-710.

• 摘要

57.  Bowers DC, Krause TP, Aronson LJ, et al. Second surgery for recurrent pilocytic astrocytoma in children. Pediatr Neurosurg. 2001;34:229-234.

• 摘要

58.  Hadjipanayis CG, Kondziolka D, Gardner P, et al. Stereotactic surgery for pilocytic astrocytomas when multimodal therapy is necessary. J Neurosurg. 2002;97:56-64.

• 摘要

59.  Pierce SM, Barnes PD, Loeffler JS, et al. Definitive radiation therapy in the management of symptomatic patients with optic nerve glioma. Survival and long-term effects. Cancer. 1990;65:45-52.

• 摘要

60.  Turgut M, Akalan N, Ozgen T, et al. Subependymal giant cell astrocytoma associated with tuberous sclerosis: diagnosis and surgical caracteristics of five cases with unusual features. Clin Neurol Neurosurg. 1996;98:217-221.

• 摘要

61.  Fouladi M, Jenkins J, Burger P, et al. Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection. Neuro Oncol. 2001;3:184-192.

• 摘要

62.  Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: EORT-22845 with the Medical Research Council Study BR04: an interim analysis. Int J Radiat Oncol Biol Phys. 2002;52:316-324.

• 摘要

63.  Shaw EG, Arusell R, Scheithauer B, et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol. 2002;20:2267-2276.

• 摘要

64.  Shaw EG, Wang M, Coons SW, et al. Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. J Clin Oncol. 2012;30:3065-3070.

• 摘要

65.  Eyre HJ, Crowley JJ, Townsend JJ, et al. A randomized trial of radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. J Neurosurg. 1993;78:909-914.

• 摘要

66.  Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-996.

• 摘要

67.  Ryken TC, Frankel B, Julien T, et al. Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery. J Neurooncol. 2008;89:271-286.

• 摘要

68.  Buatti J, Ryken TC, Smith MC, et al. Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults. J Neurooncol. 2008;89:313-337.

• 摘要

69.  Olson JJ, Ryken T. Guidelines for the treatment of newly diagnosed glioblastoma: introduction. J Neurooncol. 2008;89:255-258.

• 摘要

70.  Freeman CR, Farmer J-P. Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys. 1998;40:265-271.

• 摘要

71.  Lashford LS, Thiesse P, Jouvet A, et al. Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol. 2002;20:4684-4691.

• 摘要

72.  Pace A, Vidiri A, Galie E, et al. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol. 2003;14:1722-1726.

• 全文
• 摘要

73.  Brem H, Piantadosi S, Burger PC, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet. 1995;345:1008-1012.

• 摘要

74.  Sabel M, Giese A. Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience. Curr Med Res Opin. 2008;24:3239-3257.

• 摘要

75.  Yung WK, Prados MD, Yaya-Tur R, et al. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol. 1999;17:2762-2771.

• 摘要

76.  Brada M, Stenning S, Gabe R, et al. Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma. J Clin Oncol. 2010;28:4601-4608.

• 全文
• 摘要

77.  National Institute for Health and Care Excellence. Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal). June 2008. https://www.nice.org.uk/ (last accessed 7 October 2016).

• 全文

78.  ClinicalTrials.gov. Stage 1: marizomib + bevacizumab in WHO Gr IV GBM; Stage 2: marizomib alone. NCT02330562. September 2016. https://clinicaltrials.gov/ (last accessed 7 October 2016).

• 全文

79.  De Witt Hamer PC. Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies. Neuro Oncol. 2010;12:304-316. 


• 摘要

80.  Reardon DA, Schuster J, Dinh Tran D, et al. ReACT: overall survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma. 2015 ASCO Annual Meeting Abstracts. J Clin Oncol. 2015;33(suppl; abstr 2009).

• 全文

81.  ClinicalTrials.gov. Phase III study of rindopepimut/GM-CSF in patients with newly diagnosed glioblastoma (ACT IV). NCT01480479. January 2016. https://clinicaltrials.gov/ (last accessed 7 October 2016).

• 全文

82.  Stupp R, Wong ET, Kanner AA, et al. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer. 2012;48:2192-2202.

• 摘要

83.  Stupp R, Taillibert S, Kanner A, et al. Tumor treating fields (TTFields): a novel treatment modality added to standard chemo- and radiotherapy in newly diagnosed glioblastoma - first report of the full dataset of the EF14 randomized phase III trial. 2015 ASCO Annual Meeting Abstracts. J Clin Oncol 2015;33(suppl; abstr 2000).

• 全文

84.  Giannini C, Scheithauer BW, Burger PC, et al. Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer. 1999;85:2033-2045.

• 摘要

85.  Hamilton MG, Hull RD, Pineo GH. Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery. 1994;34:280-296.

• 摘要